Target regimen profiles for treatment of tuberculosis: a WHO document.

Autor: Lienhardt C; Global TB Programme (GTB), World Health Organization, Geneva, Switzerland lienhardtc@who.int., Nahid P; Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, San Francisco General Hospital, San Francisco, CA, USA., Rich ML; Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Partners In Health, Boston, MA, USA., Bansbach C; Global Health Program, Bill & Melinda Gates Foundation, Seattle, WA, USA., Kendall EA; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Churchyard G; Aurum Institute, Johannesburg, South Africa.; School of Public Health, University of Witwatersrand, Johannesburg, South Africa., González-Angulo L; Global TB Programme (GTB), World Health Organization, Geneva, Switzerland., D'Ambrosio L; World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, IRCCS, Tradate, Italy., Migliori GB; World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, IRCCS, Tradate, Italy., Raviglione M; Global TB Programme (GTB), World Health Organization, Geneva, Switzerland.
Jazyk: angličtina
Zdroj: The European respiratory journal [Eur Respir J] 2017 Jan 25; Vol. 49 (1). Date of Electronic Publication: 2017 Jan 25 (Print Publication: 2017).
DOI: 10.1183/13993003.02352-2016
Databáze: MEDLINE